The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment

Larissa Otero; Leonela Villegas; Moisés Huamán; Timothy Sterling; Carlos Seas

doi:10.1016/S1473-3099(17)30121-4

The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment

Larissa Otero
, Leonela Villegas
, Moisés Huamán
, Timothy Sterling
, Carlos Seas

Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado
University of Pennsylvania
University of Cincinnati College of Medicine
Vanderbilt University School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	363-364
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/S1473-3099(17)30121-4
State	Published - 1 Apr 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1473-3099(17)30121-4

Cite this

@article{a10b3161cf1a47b5a19dce11677af78f,

title = "The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment",

author = "Larissa Otero and Leonela Villegas and Mois{\'e}s Huam{\'a}n and Timothy Sterling and Carlos Seas",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/S1473-3099(17)30121-4",

language = "Ingl{\'e}s",

volume = "17",

pages = "363--364",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

number = "4",

}

TY - JOUR

T1 - The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment

AU - Otero, Larissa

AU - Villegas, Leonela

AU - Huamán, Moisés

AU - Sterling, Timothy

AU - Seas, Carlos

PY - 2017/4/1

Y1 - 2017/4/1

UR - https://www.scopus.com/pages/publications/85016168253

U2 - 10.1016/S1473-3099(17)30121-4

DO - 10.1016/S1473-3099(17)30121-4

M3 - Carta

C2 - 28346171

AN - SCOPUS:85016168253

SN - 1473-3099

VL - 17

SP - 363

EP - 364

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -

The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment

UN SDGs

Access to Document

Other files and links

Cite this